Trial Information
Monitoring Cellular Immunity After Kidney and Liver Transplantation
Inclusion Criteria:
- All patients undergoing kidney or liver transplantation at the Karolinska University
Hospital
Exclusion Criteria:
- Abscence of informed consent
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Prospective
Outcome Measure:
T cell reactivity to viral antigens
Outcome Time Frame:
Pre-transplantation and 2 weeks, 1, 3, 6 and 12 months after transplantation
Safety Issue:
No
Principal Investigator
Lars Wennberg, MD, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Karolinska University Hospital
Authority:
Sweden: Institutional Review Board
Study ID:
T cell study
NCT ID:
NCT00683748
Start Date:
March 2007
Completion Date:
March 2009
Related Keywords:
- Terminal Kidney Failure
- Terminal Liver Failure
- Transplantation
- Immunological monitoring
- Immunological risk
- T cell reactivity
- Cellular immunity
- Renal Insufficiency
- Liver Failure